Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Industries served
- Medical / Health Care
- Agriculture
- Monitoring and Testing
- Water and Wastewater
- Energy
- Environmental
- Food and Beverage
- Chemical & Pharmaceuticals
- Waste and Recycling
- Manufacturing, Other
- Mining
- Defense
- Dry Cleaning
- Electronics and Computers
- Paint
- Pulp & Paper
- Maritime/Shipbuild/Water Transport
- Textile
- Oil, Gas & Refineries
- Travel & Leisure
- Health and Safety
- Air and Climate
- Government
Immune System Suppliers In Europe
144 companies found
based inArlington, VIRGINIA (USA)
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular-therapy and regenerative-medicine markets. The fatty-acid-rich products from the company’s patented technologies protect the body’s own tissues and enable ...
MariCell XMA is a patented skin cream that has been especially developed to improve the health of red, dry and inflamed skin, including eczema prone ...
based inNewcastle Upon Tyne, UNITED KINGDOM
Our mission at Alcyomics is to provide novel solutions for the assessment of safety and efficacy of pharmaceuticals, cosmetics and chemicals. As a service provider Alcyomics aspires to take the lead in providing unique screening services enabling ...
Preclinical safety and efficacy testing of drugs as “first in man studies”, sensitisation testing of chemicals and cosmetics, safety and efficacy testing of cellular therapies. Human in vitro tests as alternative to animal models. ...
based inLublin, POLAND
We are a Polish biotechnology company with long manufacturing traditions. We have been present on the Polish and international markets since 1944. We are challenged and truly honoured to provide the leading, innovative medical solutions, and, due to ...
Onko BCG 100. Powder and solvent for suspension for intravesical use. BCG ad immunocurationem. BCG for ...
based inRichmond, VIRGINIA (USA)
GLOBAL NUTRITECH is a privately owned company established in 2006 with the vision of using biotechnology research to address problems and inefficiencies in animal production. With offices in both the United States and Turkey, GLOBAL NUTRITECH® ...
EXCELMOS is an all-natural source of mannanoligosaccharides and beta glucans derived from the cell wall of a selected strain of Saccharomyces cerevisiae at a specific temperature and ...
based inCambridge, UNITED KINGDOM
CN Bio is a leading bioengineering company specialising in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of ...
Generate human-specific pre-clinical safety and efficacy data with pioneering PhysioMimix single- and multi-organ-on-a-chip ...
based inBellinzona, SWITZERLAND
MV Biotherapeutics (MV Bio) is a early stage Swiss biotherapeutics company, and a spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland. MV Bio is developing first-in-class mucosal immune enhancers for the ...
SNP-apyrase for oral use in the treatment of IBD • Lead compound, MV010, has shown animal PoC in a murine model of ulcerative colitis. • Abrogation of the pro-inflammatory function of extracellular ATP in the intestine without ...
based inPontevedra, SPAIN
Zinereo aims to offer CDMO services of medicines and pharmaceutical-quality probiotics, tackling current human and animal health issues from a ground-breaking perspective. We are a dynamic company with over 80 ...
Bacterial vaginosis (bv) and vulvovaginal candidiasis (vvc) are the most prevalent causes of symptomatic vaginitis1 lactobacilli represent almost 90% of vaginal microbiota of healthy women. Vaginal infections are characterized by a ...
based inOlen, BELGIUM
Nutrex is a research–driven company, specialized in development, production and marketing of additives for feed. It is our aim to engage in a sustainable partnership as your most reliable supplier of optimal solutions for better nutrition. NUTREX is ...
LPS from all Gram-negative bacteria, commensal or pathogenic, share the same chemical structure, being an outer O-polysaccharide, an inner R-polysaccharide and a lipid A moiety. The latter carriers the endotoxic activity of LPS and leads to the ...
based inRapperswil, SWITZERLAND
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. ...
Stem cell transplantation is a potentially curative procedure and an established therapeutic option for a number of diseases, primarily malignant diseases of the blood. In recent years, stem cell transplantation has also become an alternative ...
based inHergiswil, SWITZERLAND
BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins for chronic diseases and immuno-therapy via our innovative formulation technology. Our company focuses on the development of ...
Due to the fact that BioLingus drug administration is sublingual, and the use of a specific carrier molecule in the BioLingus formulation, the BioLingus technology is particularly effective for sublingual immuno ...
based inParis, FRANCE
Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections and cancer. As a clinical-stage company, Abivax leverages its immune enhancing and ...
ABX196 has been developed as a synthetic agonist of iNKT cells from a proprietary platform technology that identifies cells with immune enhancing potential in cancer ...
based inLondon, UNITED KINGDOM
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic ...
Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals ...
based inKöln, GERMANY
Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking single cell analysis techniques in clinical diagnosis, drug development, and health management. Singleron Biotechnologies is an innovative ...
Singleron's sCircle technology enables full length V(D)J region sequencing at single cell level with short-read ...
based inSchönenbuch, SWITZERLAND
BÜHLMANN is a fully independent, medium sized and family owned Swiss company. The company was founded in 1976 and has continuously developed over the years. BUHLMANN continues to renew and enlarge its product port and in combining innovation with ...
based inBassevelde, BELGIUM
The B-E-St or Bio – Energy – Stimulation appliance is a technological tour de force using the injury-current or Bio - Stimulation current. By the emission of the very low strength current, B-E-St succeeds in raising the level of ATP (adenosine ...
The B-E-St Device Can Be Used In Each Form Of Therapy; Physiotherapy, Osteopathy, Manual Therapy, Wellness, Massage And Acupuncture. Western ideas in relation to the advantages of the use of micro- currents (μa) developed through the scientific ...
based inCambridge, UNITED KINGDOM
Biosceptre is a biopharmaceutical company focused on chimeric antigen receptor (CAR) T-cell therapy and immune-oncology treatment, that’s committed to bringing a new range of targeted therapies to a wide range of cancer patients. With Nobel ...
We are also developing antibodies that specifically target nfP2X7 for use in both solid and haematological tumours. Our preclinical data is very promising and studies show an excellent safety profile. By exploiting the modular nature of the antibody ...
based inHertfordshire, UNITED KINGDOM
Fluidic Sciences Ltd specializes in microfluidic technologies for accelerating protein interaction analysis and single-cell screening. Their flagship product, Fluidity One-M, enables rapid measurements of binding affinity, concentration, ...
Fluidic Sciences Ltd. offers the Fluidity One-M instrument, integrated with Microfluidic Diffusional Sizing (MDS) technology, specifically engineered for in-solution analysis of antibodies and their targets throughout various stages of development. ...
based inHamburg, GERMANY
Berg Schmidt is a member of the Stern-Wywiol Gruppe, an internationally successful enterprise in the field of Food & Feed Ingredients. Berg Schmidt is an old-established Hamburg company with more than 60 years’ experience in the development, ...
Conjugated linoleic acid (omega- 6 essential unsaturated fatty ...
based inVienna, AUSTRIA
Hookipa Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system. We are using our non-replicating and ...
Our scientific platform includes two distinct approaches to arenavirus-based therapies: replicating and non-replicating. Our replicating technology is designed to create a stronger immune response that we believe is more appropriate for use in ...
based inLachen, SWITZERLAND
We are the largest privately owned and independent plasma fractionator in the world. Family-owned since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 118 ...
octagam® 5% (50 mg/ml), Human Normal Immunoglobulin. octagam® 10% (100 mg/ml), Human Normal Immunoglobulin. Liquid, ready-to-use intravenous immunoglobulin ...